Relapsing–remitting multiple sclerosis patients showed a significantly enhanced Th1 cell response compared to SPMS and PPMS, which contradicts the differences observed in IFN-γ levels. This evidence concerns the gene IFNG and secondary progressive multiple sclerosis.